Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 19Triple Negative Breast Neoplasms 2Cardiotoxicity 2Ovarian Neoplasms 1Obesity 1Inflammation 1Hot Flashes 1Highly Endocrine Responsive Operable Breast Cancer 1Genetic Diseases, Inborn 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Advanced Breast Cancer 1

Interventions

Tablets 1Letrozole 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Highly Endocrine Responsive Operable Breast Cancer × Tablets × Breast × Clear all
NCT03397537 2018-01-17

Neoadjuvant Endocrine Therapy in Breast Cancer

Guangdong Provincial People's Hospital

Phase 2 Completed
46 enrolled
Breast

Highly Endocrine Responsive Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡